The future of molecular genetic testing.

The potential applications for genetic testing are immense, with most diseases having some aspect influenced by, if not directly caused by, changes in the genome of the patient. The translation of genetic information into medical applications will be influenced by our understanding of the human genome, technological advances, and social, ethical, and legal issues surrounding genetic testing. With time, new genetic information will be translated into clinical tests for the diagnosis of current illness and prediction of future disease risk, and will be used for the development of genetically directed therapies and preventive interventions. Most genetic testing will be highly automated, with only rare genetic disease tests performed manually. The challenge for the clinical genetic laboratory is to keep pace with this information explosion to provide state-of-the-art genetic testing and to ensure that the genetic test results are used in a morally, ethically, and socially responsible way.

[1]  D. Seligson,et al.  Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.

[2]  C. Cantor,et al.  A strategy for rapid and efficient DNA sequencing by mass spectrometry , 1996, Nature Biotechnology.

[3]  E. Kmiec,et al.  Targeted gene correction: a new strategy for molecular medicine. , 1998, Molecular medicine today.

[4]  R. Munford,et al.  Physiologically responsive gene therapy. , 1998, Molecular medicine today.

[5]  J. Hodgson,et al.  DNA chips: An array of possibilities , 1998, Nature Biotechnology.

[6]  A. Persidis Pharmacogenomics and diagnostics , 1998, Nature Biotechnology.

[7]  David Housman,et al.  Why pharmacogenomics? Why now? , 1998, Nature Biotechnology.

[8]  G. Ramsay DNA chips: State-of-the art , 1998, Nature Biotechnology.

[9]  F. Collins,et al.  New goals for the U.S. Human Genome Project: 1998-2003. , 1998, Science.

[10]  W. Evans,et al.  Pharmacogenetics of cancer therapy: getting personal. , 1998, American journal of human genetics.

[11]  E. Boerwinkle,et al.  DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene , 1998, Nature Genetics.

[12]  Charles R. Cantor,et al.  Sequencing exons 5 to 8 of the p53 gene by MALDI-TOF mass spectrometry , 1998, Nature Biotechnology.

[13]  W. KALOWa Pharmacogenetics in Biological Perspective , 1998 .